Navigating the Balance: Pharma’s Utilization of AI, Speculation, and Empirical Data

Pursuing innovation is both a driving force and a delicate balancing act. Companies constantly seek breakthroughs that could transform healthcare but must also navigate the intricate dance between speculation and empirical evidence. With the advent of artificial intelligence (AI), this balance has taken on a new dimension, offering potential business benefits and recognized security risks.

Speculation vs. Empirical Evidence: The Pharma Conundrum